These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland. Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D. Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931 [Abstract] [Full Text] [Related]
23. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report. Alabdulqader M, Alfakeeh K. BMC Nephrol; 2021 Apr 20; 22(1):140. PubMed ID: 33879077 [Abstract] [Full Text] [Related]
25. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance. Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H. Clin Exp Nephrol; 2019 Jan 20; 23(1):65-75. PubMed ID: 29959568 [Abstract] [Full Text] [Related]
28. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report. Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A. J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370 [Abstract] [Full Text] [Related]
29. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report. Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G. Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717 [Abstract] [Full Text] [Related]
35. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H, Chaudhuri A, Concepcion W, Grimm PC. Pediatr Nephrol; 2014 Mar 04; 29(3):477-80. PubMed ID: 24221349 [Abstract] [Full Text] [Related]
36. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era. Avila Bernabeu AI, Cavero Escribano T, Cao Vilarino M. Nephron; 2020 Mar 04; 144(11):537-549. PubMed ID: 32950988 [Abstract] [Full Text] [Related]
37. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N. Intern Med J; 2015 Oct 04; 45(10):1054-65. PubMed ID: 26247170 [Abstract] [Full Text] [Related]